Skip to main content
. 2026 Jul 17;14(7):1617. doi: 10.3390/biomedicines14071617
AE Adverse event
ARDS Acute respiratory distress syndrome
BCMA B-cell maturation antigen
BID Twice daily
CAR Chimeric antigen receptor
CI Confidence interval
COVID-19 Coronavirus disease 2019
CRP C-reactive protein
EV Extracellular vesicle
GPRC5D G protein-coupled receptor family C group 5 member D
IFN Interferon
IL Interleukin
ITT Intention-to-treat
JAK Janus kinase
MHC Major histocompatibility complex
miRNA MicroRNA
MM Multiple myeloma
MSC Mesenchymal stem cell
NK Natural killer
PCR Polymerase chain reaction
RR Relative risk
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
sEV Small extracellular vesicle
TGF-β Transforming growth factor-beta
TNF Tumor necrosis factor
VFD Ventilator-free days